KR20220047974A - 방사성 금속 착체의 제조 방법 - Google Patents

방사성 금속 착체의 제조 방법 Download PDF

Info

Publication number
KR20220047974A
KR20220047974A KR1020227004086A KR20227004086A KR20220047974A KR 20220047974 A KR20220047974 A KR 20220047974A KR 1020227004086 A KR1020227004086 A KR 1020227004086A KR 20227004086 A KR20227004086 A KR 20227004086A KR 20220047974 A KR20220047974 A KR 20220047974A
Authority
KR
South Korea
Prior art keywords
radioactive metal
ligand
water
metal complex
reaction solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020227004086A
Other languages
English (en)
Korean (ko)
Inventor
토모유키 이마이
마사토 키리우
아키히로 이자와
Original Assignee
니혼 메디피직스 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 니혼 메디피직스 가부시키가이샤 filed Critical 니혼 메디피직스 가부시키가이샤
Publication of KR20220047974A publication Critical patent/KR20220047974A/ko
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/002—Heterocyclic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/004—Acyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F19/00—Metal compounds according to more than one of main groups C07F1/00 - C07F17/00
    • C07F19/005—Metal compounds according to more than one of main groups C07F1/00 - C07F17/00 without metal-C linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/003—Compounds containing elements of Groups 4 or 14 of the Periodic Table without C-Metal linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/05—Isotopically modified compounds, e.g. labelled

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
KR1020227004086A 2019-08-21 2020-08-04 방사성 금속 착체의 제조 방법 Ceased KR20220047974A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JPJP-P-2019-151480 2019-08-21
JP2019151480 2019-08-21
PCT/JP2020/029757 WO2021033530A1 (ja) 2019-08-21 2020-08-04 放射性金属錯体の製造方法

Publications (1)

Publication Number Publication Date
KR20220047974A true KR20220047974A (ko) 2022-04-19

Family

ID=74660922

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020227004086A Ceased KR20220047974A (ko) 2019-08-21 2020-08-04 방사성 금속 착체의 제조 방법

Country Status (9)

Country Link
US (1) US20220259160A1 (https=)
EP (1) EP4019502A4 (https=)
JP (2) JP7744828B2 (https=)
KR (1) KR20220047974A (https=)
CN (1) CN114269724A (https=)
AU (1) AU2020332618A1 (https=)
CA (1) CA3148288A1 (https=)
TW (1) TW202120483A (https=)
WO (1) WO2021033530A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022149578A1 (ja) 2021-01-08 2022-07-14 日本メジフィジックス株式会社 Ａｃ－２２５溶液の製造方法およびＡｃ－２２５溶液を用いた医薬の製造方法
EP4442285A1 (en) 2021-11-30 2024-10-09 Nihon Medi-Physics Co., Ltd. Stabilized radiopharmaceutical composition

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050191239A1 (en) 2003-12-01 2005-09-01 Immunomedics, Inc. Method for preparing conjugates of proteins and chelating agents

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6670456B2 (en) * 2001-02-28 2003-12-30 Dow Global Technologies Inc. Actinium-225 complexes and conjugates for targeted radiotherapy
US7597876B2 (en) * 2007-01-11 2009-10-06 Immunomedics, Inc. Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules
WO2008009444A1 (en) * 2006-07-19 2008-01-24 Van Dulmen, Adrianus, A. Use of ethanol for stabilizing a single-vial liquid formulation of a radiolabeled peptide
AU2010326004B2 (en) * 2009-12-04 2016-04-21 Immunomedics, Inc. Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules
DE102012019714B4 (de) * 2012-10-08 2022-04-28 Johannes Gutenberg-Universität Mainz Verfahren zur Herstellung von pharmakologischen Metall-Ligand-Konjugaten
US20140147381A1 (en) * 2012-11-29 2014-05-29 Gregory David Espenan 89zr compounds, to include somatostatin, apparatus and products comprising such compounds, methods of making same, and methods of using same for radio imaging and/or treatment
JP2017503763A (ja) * 2013-12-03 2017-02-02 ミレニアム ファーマシューティカルズ， インコーポレイテッドＭｉｌｌｅｎｎｉｕｍ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． Ｇｃｃ発現細胞を撮像するための化合物及び組成物
WO2017161356A1 (en) * 2016-03-18 2017-09-21 Wake Forest University Compounds, compositions and associated methods using zirconium-89 in immuno-positron emission tomography
EP3609541A4 (en) * 2017-04-05 2021-04-07 Cornell University Trifunctional constructs with tunable pharmacokinetics useful in imaging and anti-tumor therapies
JP2019151480A (ja) 2018-03-06 2019-09-12 富士ゼロックス株式会社 検知装置及び画像形成装置
US12351890B2 (en) * 2019-07-30 2025-07-08 Jfe Engineering Corporation Method for synthesizing zirconium complex

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050191239A1 (en) 2003-12-01 2005-09-01 Immunomedics, Inc. Method for preparing conjugates of proteins and chelating agents

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Eppard et al., EJNMMI Radiopharm. Chem. 2017;1,6.
Pandya et al., Chem Sci. 2017;8(3):2309-14.
Perez-Malo et al., Inorg. Chem. 2018, 57(10), 6107-6117.

Also Published As

Publication number Publication date
EP4019502A1 (en) 2022-06-29
JP7744828B2 (ja) 2025-09-26
US20220259160A1 (en) 2022-08-18
CA3148288A1 (en) 2021-02-25
EP4019502A4 (en) 2023-08-16
CN114269724A (zh) 2022-04-01
TW202120483A (zh) 2021-06-01
JP2025116040A (ja) 2025-08-07
JPWO2021033530A1 (https=) 2021-02-25
AU2020332618A1 (en) 2022-02-24
WO2021033530A1 (ja) 2021-02-25

Similar Documents

Publication Publication Date Title
Shetty et al. Stable aluminium fluoride chelates with triazacyclononane derivatives proved by X-ray crystallography and 18 F-labeling study
Paterson et al. Versatile new bis (thiosemicarbazone) bifunctional chelators: synthesis, conjugation to bombesin (7− 14)-NH2, and copper-64 radiolabeling
JP2025116040A (ja) 放射性金属錯体の製造方法
US5601800A (en) New multifunctional ligands for potential use in the design therapeutic or diagnostic radiopharmaceutical imaging agents
Procházková et al. Lanthanide (III) complexes of monophosphinate/monophosphonate DOTA-analogues: effects of the substituents on the formation rate and radiolabelling yield
Moore et al. “Click” labeling strategy for M (CO) 3 (M= Re, 99mTc) prostate cancer targeted Flutamide agents
Lipowska et al. fac-99mTc/Re-tricarbonyl complexes with tridentate aminocarboxyphosphonate ligands: Suitability of the phosphonate group in chelate ligand design of new imaging agents
Försterová et al. Chemical and biological evaluation of 153Sm and 166Ho complexes of 1, 4, 7, 10-tetraazacyclododecane-1, 4, 7, 10-tetrakis (methylphosphonic acid monoethylester)(H4dotpOEt)
KR20240037178A (ko) Mri 조영제로서 혼합 하이드록실 펜던트를 갖는 철(iii) 매크로사이클릭 복합체
Levason et al. [AlCl 3 (BnMe 2-tacn)]–a new metal chelate scaffold for radiofluorination by Cl/F exchange
Gano et al. Radiolanthanide complexes with tetraazamacrocycles bearing methylphosphonate pendant arms as bone seeking agents
US7160536B2 (en) Radiolabelled metal transport proteins as imaging agents
US11690923B2 (en) Multinuclear complexes and their preparation
HK40066248A (zh) 放射性金属络合物的制造方法
Chauhan et al. 68Ga-Labeled bismacrocyclic methylene phosphonate as potential bone seeking PET radiopharmaceutical
Thieme et al. Synthesis, characterization and biological evaluation of [188Re (N)(cys∼)(PNP)]+/0 mixed-ligand complexes as prototypes for the development of 188Re (N)-based target-specific radiopharmaceuticals
KR20160144352A (ko) 방사성의약품 제조용 키트
EP3377504B1 (en) Cyclam based compounds, their conjugates, co-ordination compounds, pharmaceutical compositions thereof, method of preparation and use thereof
Perils et al. Novel rhenium (V) nitride complexes with dithiocarbimate ligands–A synchrotron X-ray and DFT structural investigation
US6979431B2 (en) Method for labelling technetium or rhenium using borohydride exchange resin
O'Callaghan et al. Synthesis and properties of metal trifluoride complexes with amide-functionalised tacn macrocycles and radiofluorination of [GaF 3 (L1)] by 18 F/19 F isotopic exchange
Kubeil et al. Copper (II) Cyclam Complexes with N‐Propionic Acid Pendant Arms
Hayes Technetium-99m carbonyl complexes and new ligand development for targeted radiopharmaceuticals
TW202222352A (zh) 放射性鋯錯合物之製造方法
CN105175454B (zh) 一种99mTcN核标记阿仑膦酸氨荒酸盐配合物及制备方法和应用

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11 Administrative time limit extension requested

Free format text: ST27 STATUS EVENT CODE: U-3-3-T10-T11-OTH-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

E13 Pre-grant limitation requested

Free format text: ST27 STATUS EVENT CODE: A-2-3-E10-E13-LIM-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-NAP-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

B15 Application refused following examination

Free format text: ST27 STATUS EVENT CODE: N-2-6-B10-B15-EXM-PE0601 (AS PROVIDED BY THE NATIONAL OFFICE)

PE0601 Decision on rejection of patent

St.27 status event code: N-2-6-B10-B15-exm-PE0601